Interactions of a novel inhibitor from an extremophilic Bacillus sp with HIV-1 protease -: Implications for the mechanism of inactivation

被引:18
作者
Dash, C [1 ]
Rao, M [1 ]
机构
[1] Natl Chem Lab, Div Biochem Sci, Pune 411008, Maharashtra, India
关键词
D O I
10.1074/jbc.M005662200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The active site cleft of the HIV-1 protease (PR) is bound by two identical conformationally mobile loops known as flaps, which are important for substrate binding and catalysis, The present article reports, for the first time, an HIV-1 PR inhibitor, ATBI, from an extremophilic Bacillus sp. The inhibitor is found to be a hydrophilic peptide with Mr of 1147, and an amino acid sequence of Ala-Gly-Lys-Lys-Asp-Asp-Asp-Asp-Pro-Pro-Glu, Sequence homology exhibited no similarity with the reported peptidic inhibitors of HIV-1 PR. Investigation of the kinetics of the enzyme-inhibitor interactions revealed that ATBI is a noncompetitive and tight binding inhibitor with the IC50 and K-i values 18.0 and 17.8 nM, respectively. The binding of the inhibitor with the enzyme and the subsequent induction of the localized conformational changes in the flap region of the HIV-1 PR were monitored by exploiting the intrinsic fluorescence of the surface exposed Trp-42 residues, which are present at the proximity of the flaps. We have demonstrated by fluorescence and circular dichroism studies that ATBI binds in the active site of the HIV-1 PR and thereby leads to the inactivation of the enzyme. Based on our results, we propose that the inactivation is due to the reorganization of the flaps impairing its flexibility leading toward inaccessibility of the substrate to the active site of the enzyme.
引用
收藏
页码:2487 / 2493
页数:7
相关论文
共 43 条
  • [21] Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease
    Louis, JM
    Dyda, F
    Nashed, NT
    Kimmel, AR
    Davies, DR
    [J]. BIOCHEMISTRY, 1998, 37 (08) : 2105 - 2110
  • [22] HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE EXPRESSED IN ESCHERICHIA-COLI BEHAVES AS A DIMERIC ASPARTIC PROTEASE
    MEEK, TD
    DAYTON, BD
    METCALF, BW
    DREYER, GB
    STRICKLER, JE
    GORNIAK, JG
    ROSENBERG, M
    MOORE, ML
    MAGAARD, VW
    DEBOUCK, C
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (06) : 1841 - 1845
  • [23] PROTEINOTOPIC FEATURE MAPS
    MERELO, JJ
    ANDRADE, MA
    PRIETO, A
    MORAN, F
    [J]. NEUROCOMPUTING, 1994, 6 (04) : 443 - 454
  • [24] STRUCTURE OF COMPLEX OF SYNTHETIC HIV-1 PROTEASE WITH A SUBSTRATE-BASED INHIBITOR AT 2.3-A RESOLUTION
    MILLER, M
    SCHNEIDER, J
    SATHYANARAYANA, BK
    TOTH, MV
    MARSHALL, GR
    CLAWSON, L
    SELK, L
    KENT, SBH
    WLODAWER, A
    [J]. SCIENCE, 1989, 246 (4934) : 1149 - 1152
  • [25] CRYSTAL-STRUCTURE OF A RETROVIRAL PROTEASE PROVES RELATIONSHIP TO ASPARTIC PROTEASE FAMILY
    MILLER, M
    JASKOLSKI, M
    RAO, JKM
    LEIS, J
    WLODAWER, A
    [J]. NATURE, 1989, 337 (6207) : 576 - 579
  • [26] A computational study of the resistance of HIV-1 aspartic protease to the inhibitors ABT-538 and VX-478 and design of new analogues
    Nair, AC
    Miertus, S
    Tossi, A
    Romeo, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 242 (03) : 545 - 551
  • [27] 3-DIMENSIONAL STRUCTURE OF ASPARTYL PROTEASE FROM HUMAN IMMUNODEFICIENCY VIRUS HIV-1
    NAVIA, MA
    FITZGERALD, PMD
    MCKEEVER, BM
    LEU, CT
    HEIMBACH, JC
    HERBER, WK
    SIGAL, IS
    DARKE, PL
    SPRINGER, JP
    [J]. NATURE, 1989, 337 (6208) : 615 - 620
  • [28] OROSZLAN S, 1990, CURR TOP MICROBIOL, V157, P153
  • [29] PAWAR HS, 1988, J BIOSCIENCE, V3, P43
  • [30] A STRUCTURAL MODEL FOR THE RETROVIRAL PROTEASES
    PEARL, LH
    TAYLOR, WR
    [J]. NATURE, 1987, 329 (6137) : 351 - 354